Skip to main content

Select Drug Profiles

Original Research

Hypertension Management: An Update

Joann Dominguez, MD, Loida Nguyen, PharmD, Nageshwara Gullapalli, MD, Quang T. Nguyen, DO, FACE, FTOS

Stakeholder Perspective

Hypertension Management: Implications to Patients, Providers, and Payers

by Lekshmi Dharmarajan, MD, FACP, FACC

Practice Management

Competition from Biosimilars an Incentive for Innovation

Dalia Buffery, MA, ABD

Practice Management

Emerging Trends in Breast Cancer Management

Caroline Helwick

Practice Management

Rheumatology Pipeline Boasts Innovation, ID Line Is Drying Up: ACR/IDSA 2009

Practice Management

Cardiology Pipeline Is Promising: AHA 2009

Wellness and the Governing Dynamics of Healthcare Reform

Robert E. Henry

Doctors on Healthcare Reform

Betsy McCaughey

Practice Management

Health Plan Retention and Pharmacy Costs of Newly Diagnosed Patients with Chronic Kidney Disease in a Managed Care Population

Maureen Kubacki, PharmD, MBA , Chureen Carter, PharmD, MS , Alan D. L. Herrera, PharmD, Jim Wang, PhD, Janice M.S. Lopez, PharmD, MPH, Catherine T. Piech, MBA

Stakeholder Perspective

Alignment of Incentives along the Healthcare Payer Continuum for Patients with Kidney Disease

by Jeff Januska, PharmD

Practice Management

Quality Improvement Initiatives: The Missed Opportunity for Health Plans

Sara Fernandez-Lopez, PhD, Jeffrey A. Bourret, PharmD, Barbara Lennert, RN, BSN, MAOM

Stakeholder Perspective

The Missing Quality Standard for Medication Adherence

Original Research

Economic Evaluation of Quality-of-Life Improvement with Second-Generation Antihistamines and Montelukast in Patients with Allergic Rhinitis

Kim Saverno, PhD, Brian Seal, PhD, Michael J. Goodman, PhD, Kellie Meyer, PharmD

Stakeholder Perspective

Allergic Rhinitis: A Serious Condition with Many Safe and Effective Pharmaceutical Options

by Paul Anthony Polansky, BSPharm, MBA

Page 241 of 244
Results 2401 - 2410 of 2434